U.S. Food and Drug Administration-approved artificial intelligence-based algorithms are rapidly growing in number. These algorithms are, for the most part, designed to help healthcare providers implement existing workflows more efficiently in a variety of fields, the two most popular being cardiology and radiology. This article provides a high-level overview of recent developments in the world of artificial intelligence and attempts to identify some of the associated liabilities, particularly in the context of product liability.
Originally published in For The Defense - September 2020.
Please see full Publication below for more information.